ZG006 Clinical Trials
8 recruitingBiologic
Phase 17Phase 25Phase 31
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
Study of ZGGS34 in Participants With Advanced Solid Tumors
Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd400 enrolled1 locationNCT07258121
Recruiting
Phase 1
Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer
Small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd100 enrolled1 locationNCT07231445
Recruiting
Phase 3
Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer
Small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd420 enrolled1 locationNCT07189455
Recruiting
Phase 1Phase 2
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Small Cell Lung CancerNeuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd350 enrolled1 locationNCT07038096
Recruiting
Phase 1Phase 2
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Small Cell Lung CancerNeuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd54 enrolled1 locationNCT05978284
Recruiting
Phase 1Phase 2
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
Small Cell Lung CancerNeuroendocrine Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd265 enrolled1 locationNCT06283719
Recruiting
Phase 1
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
Small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd30 enrolled6 locationsNCT06592638
Recruiting
Phase 1Phase 2
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.
Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd78 enrolled1 locationNCT06440057